Helga Raab

8.4k citations

26 papers · 3.8k indexed · 3 hit papers · h-index 22

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research
Oncology top 1%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis

Papers in

Radiology, Nuclear Medicine and Imaging 18
- Monoclonal and Polyclonal Antibodies Research 17
- Radiopharmaceutical Chemistry and Applications 2
Oncology 19
- HER2/EGFR in Cancer Research 14
- Peptidase Inhibition and Analysis 7
- CAR-T cell therapy research 4

Co-authors: Jagath R. Junutula Sunil Bhakta David V. Goeddel Paul Polakis William J. Kohr Siler H. Panowski Richard Vandlen Gail D. Lewis Phillips
Journals: Journal of Biological Chemistry (4 papers)Bioconjugate Chemistry (3 papers)Clinical Cancer Research (2 papers)Cell (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United States France Italy

In The Last Decade

Helga Raab

26 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Site-specific antibody drug conjugates for cancer therapy 2013 · 517 citations

Peers

Countries citing papers authored by Helga Raab

Since Specialization

Citations

This map shows the geographic impact of Helga Raab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Raab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Raab more than expected).

Fields of papers citing papers by Helga Raab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Raab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Raab. The network helps show where Helga Raab may publish in the future.

Co-authors

The 25 scholars most cited alongside Helga Raab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helga Raab Line = papers co-authored together Helga Raab links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers Journal of Medicinal Chemistry ·Stephen J. Gregson, Luke A. Masterson, BinQing Wei, Thomas H. Pillow, Susan D. Spencer, Gyoung‐Dong Kang, Shang‐Fan Yu, Helga Raab, Jeffrey Lau, Guangmin Li, Gail D. Lewis Phillips, Janet Gunzner-Toste, Brian S. Safina, Rachana Ohri, Martine Darwish, Katherine R. Kozak, Josefa dela Cruz-Chuh, Andrew G. Polson, John A. Flygare, Philip W. Howard	2017	27
2	A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs Clinical Cancer Research ·Shang‐Fan Yu, Bing Zheng, MaryAnn Go, Jeff Lau, Susan D. Spencer, Helga Raab, Robert Soriano, Suchit Jhunjhunwala, Robert Cohen, Michele Caruso, Paul Polakis, John A. Flygare, Andrew G. Polson	2015	125
3	The cryptophycins as potent payloads for antibody drug conjugates Bioorganic & Medicinal Chemistry Letters ·Vishal Verma, Thomas H. Pillow, Laura DePalatis, Guangmin Li, Gail D. Lewis Phillips, Andrew G. Polson, Helga Raab, Susan D. Spencer, Bing Zheng	2015	51
4	Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates Pharmaceutical Research ·Siddharth Sukumaran, Kapil Gadkar, Crystal Zhang, Sunil Bhakta, Luna Liu, Keyang Xu, Helga Raab, Shang‐Fan Yu, Elaine Mai, Aimee Fourie-O’Donohue, Katherine R. Kozak, Saroja Ramanujan, Jagath R. Junutula, Kedan Lin	2014	32
5	Site-specific antibody drug conjugates for cancer therapy mAbs ·Siler H. Panowski, Sunil Bhakta, Helga Raab, Paul Polakis, Jagath R. Junutula Hit paper breakdown →	2013	517
6	Engineering THIOMABs for Site-Specific Conjugation of Thiol-Reactive Linkers Methods in molecular biology ·Sunil Bhakta, Helga Raab, Jagath R. Junutula	2013	49
7	The Melanosomal Protein PMEL17 as a Target for Antibody Drug Conjugate Therapy in Melanoma Journal of Biological Chemistry ·Youjun Chen, Cécile Chalouni, Christine Tan, Robyn Clark, Rayna Venook, Rachana Ohri, Helga Raab, Ron Firestein, William Mallet, Paul Polakis	2012	21
8	Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry Analytical Biochemistry ·Keyang Xu, Luna Liu, Ola M. Saad, Jakub Baudys, Lara Williams, Douglas D. Leipold, Ben Shen, Helga Raab, Jagath R. Junutula, Amy Kim, Surinder Kaur	2011	122
9	Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Clinical Cancer Research ·Jagath R. Junutula, Kelly M. Flagella, Richard Graham, Kathryn L. Parsons, Edward Ha, Helga Raab, Sunil Bhakta, Trung Van Nguyen, Debra L. Dugger, Guangmin Li, Elaine Mai, Gail D. Lewis Phillips, Hajime Hiraragi, Reina N. Fuji, Jay Tibbitts, Richard Vandlen, Susan D. Spencer, Richard H. Scheller, Paul Polakis, Mark X. Sliwkowski	2010	214
10	In vivoeffects of targeting CD79b with antibodies and antibody-drug conjugates Molecular Cancer Therapeutics ·Bing Zheng, Reina N. Fuji, Kristi Elkins, Shang‐Fan Yu, Franklin Fuh, Josefa Chuh, Christine Tan, Jo-Anne Hongo, Helga Raab, Katherine R. Kozak, Marna Williams, Elena McDorman, Dan Eaton, Allen Ebens, Andrew G. Polson	2009	42
11	Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs Journal of Immunological Methods ·Jagath R. Junutula, Sunil Bhakta, Helga Raab, Karen E. Ervin, Charles Eigenbrot, Richard Vandlen, Richard H. Scheller, Henry B. Lowman	2008	128
12	Anti-CD22-MCC-DM1 and MC-MMAF Conjugates: Impact of Assay Format on Pharmacokinetic Parameters Determination Bioconjugate Chemistry ·Jean-Philippe Stéphan, Pamela Chan, Chien Lee, Christopher A. Nelson, J. Michael Elliott, Charity Bechtel, Helga Raab, David Xie, Jon Akutagawa, Jakub Baudys, Ola M. Saad, Saileta Prabhu, Wai Lee Wong, Richard Vandlen, Fred Jacobson, Allen Ebens	2008	53
13	Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains Journal of Biological Chemistry ·Pierre A. Barthelemy, Helga Raab, B.A. Appleton, Christopher J. Bond, Ping Wu, Christian Wiesmann, Sachdev S. Sidhu	2007	145
14	Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity Journal of Biological Chemistry ·Conrad Yap Edosada, Clifford Quan, Christian Wiesmann, Thuy Tran, Dan Sutherlin, Mark Reynolds, J. Michael Elliott, Helga Raab, Wayne J. Fairbrother, Beni B. Wolf	2006	1
15	Rapid removal of N-linked oligosaccharides using microwave assisted enzyme catalyzed deglycosylation International Journal of Mass Spectrometry ·Wendy Sandoval, F Arellano, David Arnott, Helga Raab, Richard Vandlen, Jennie R. Lill	2006	43
16	Disulfide locked variants of factor VIIa with a restricted β‐strand conformation have enhanced enzymatic activity Protein Science ·Henry R. Maun, Charles Eigenbrot, Helga Raab, David Arnott, Lilian Phu, Sherron Bullens, Robert A. Lazarus	2005	10
17	Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3 Cell ·Paul J. Godowski, Melanie R. Mark, Jian Chen, M D Sadick, Helga Raab, R. Glenn Hammonds	1995	186
18	Identification of Heregulin, a Specific Activator of p185 ^erbB2 Science ·William E. Holmes, Mark X. Sliwkowski, Robert W. Akita, William J. Henzel, James Lee, John W. Park, Daniel G. Yansura, Nasrin Abadi, Helga Raab, Gail D. Lewis Phillips, H. Michael Shepard, Wun-Jing Kuang, William l. Wood, David V. Goeddel, Richard Vandlen Hit paper breakdown →	1992	845
19	Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor .alpha. induced receptor aggregation Biochemistry ·Diane Pennica, William J. Kohr, B M Fendly, Steven J. Shire, Helga Raab, Paul E. Borchardt, Martyn Lewis, David V. Goeddel	1992	62
20	Molecular cloning and expression of a receptor for human tumor necrosis factor Cell ·Thomas J. Schall, Martyn Lewis, Kerry J. Koller, Angela Lee, Glenn C. Rice, G H Wong, Tetsuya Gatanaga, Gale A. Granger, Rigdon Lentz, Helga Raab, William J. Kohr, David V. Goeddel Hit paper breakdown →	1990	852

About Helga Raab

Helga Raab is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology and Allergy, Immunology and Molecular Biology, having authored 26 papers that have together received 3.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (17 papers), HER2/EGFR in Cancer Research (14 papers), Peptidase Inhibition and Analysis (7 papers), CAR-T cell therapy research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Neuropeptides and Animal Physiology (2 papers), Cell Adhesion Molecules Research (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.7k citations), Oncology (1.7k citations), Immunology (1.0k citations), Immunology and Allergy (242 citations) and Molecular Biology (1.8k citations). Helga Raab has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Jagath R. Junutula, Sunil Bhakta, David V. Goeddel, Paul Polakis, William J. Kohr, Siler H. Panowski, Richard Vandlen, Gail D. Lewis Phillips, Glenn C. Rice and Kerry J. Koller. Their work appears in journals such as Journal of Biological Chemistry, Bioconjugate Chemistry, Clinical Cancer Research, Cell and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact